title: Letter in response to "Idarucizumab for dabigatran overdose".
authors.affiliation: a Emergency Medicine Residency program , McGill University , Montreal , Canada.
authors.forename: Josh J
authors.initials: JJ
authors.lastname: Wang
authors.affiliation: b Department of Pharmacy , McGill University Health Centre , Montreal , Canada.
authors.forename: Eric
authors.initials: E
authors.lastname: Villeneuve
authors.affiliation: c Centre Antipoison du Quebec , Quebec , Canada.|d Departments of Medicine and Emergency Medicine , McGill University Health Centre , Montreal , Canada.
authors.forename: Sophie
authors.initials: S
authors.lastname: Gosselin
mesh_terms: D000991:Antithrombins / Q000627:therapeutic use*; D000069604:Dabigatran; D062787:Drug Overdose / Q000188:drug therapy; D006801:Humans
chemical_list: D000991:Antithrombins; D000069604:Dabigatran